Johnson & Johnson (JNJ) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Sep 10, 2026.
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
- Filings shown
- 9
- Open-market buys
- 0
- Open-market sells
- 10
Counts cover the 9 most recent Form 4 filings Tradune holds for JNJ (filed Jul 21 – Sep 10, 2026); the score below covers only the trailing 90 days (0 buys, 9 sells). No completed check of JNJ's Form 4 list on SEC EDGAR is on record yet; the latest JNJ filing Tradune holds was filed Sep 10, 2026. This is not guaranteed to be the complete record — see JNJ's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 8 filings Tradune holds for JNJ filed Aug 7 – Sep 10, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
9 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 0 sales· 0 sh
- checkbox disclosed
- On filings with the box not checked
- 0 sales· 0 sh
- not proof that no plan exists
- Not comparable
- 9 sales· 236,286 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Joaquin DuatoDirector & Officer | 0 | 4 | — | 171,771 | −$44,714,937 |
| Timothy SchmidEVP, WW Chair, MedTech | 0 | 2 | — | 33,597 | −$9,230,440 |
| Elizabeth ForminardEVP, Chief Legal Officer | 0 | 2 | — | 15,918 | −$4,090,960 |
| Jennifer L. TaubertEVP, WWC. Innovative Medicine | 0 | 1 | — | 15,000 | −$3,950,400 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at JNJ
No open-market insider purchases (Form 4 code P) were reported for JNJ between Jul 21, 2026 and Sep 10, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Share Units | 113 | $276.31 | — | — | Sep 8, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Share Units | 136 | $276.31 | — | — | Sep 8, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Share Units | 181 | $276.31 | — | — | Sep 8, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale | 22,527 | $274.74 | — | — | Sep 2, 2026 |
| Option exercise | 11,070 | $131.94 | — | — | Sep 2, 2026 |
| Open-market sale | 11,070 | $274.74 | — | — | Sep 2, 2026 |
| Option exercise | 22,527 | $151.41 | — | — | Sep 2, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale | 15,000 | $263.36 | — | — | Aug 17, 2026 |
| Option exercise | 15,000 | $115.67 | — | — | Aug 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale | 20,976 | $262.00 | — | — | Aug 13, 2026 |
| Open-market sale | 102,315 | $261.00 | — | — | Aug 13, 2026 |
| Option exercise | 123,291 | $115.67 | — | — | Aug 13, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 9,344 | $131.94 | — | — | Aug 6, 2026 |
| Open-market sale | 6,574 | $255.93 | — | — | Aug 6, 2026 |
| Open-market sale | 9,344 | $257.76 | — | — | Aug 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale | 41,957 | $258.06 | — | — | Aug 5, 2026 |
| Open-market sale | 6,523 | $258.74 | — | — | Aug 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 11,129 | $129.51 | — | — | Jul 20, 2026 |
| Option exercise | 11,925 | $131.94 | — | — | Jul 20, 2026 |
| Open-market sale | 23,054 | $251.27 | — | — | Jul 20, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to JNJ's (Sep 10, 2026).
Frequently asked about JNJ insider activity
How many insiders bought JNJ stock in these Form 4 filings?
No open-market purchases (Form 4 code P) of JNJ shares were reported by Johnson & Johnson insiders between Jul 21, 2026 and Sep 10, 2026. The 9 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.
Who filed the most recent Form 4 for JNJ?
The most recent Form 4 on this page was filed by Marillyn A. Hewson (Director) on Sep 10, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market JNJ insider sale shown?
The largest open-market sale among the filings shown was 102,315 JNJ shares at $261.00 (about $26,704,215) by Joaquin Duato (Director & Officer) on Aug 13, 2026. Value is shares × the price reported on the Form 4; trades may be made under a prearranged Rule 10b5-1 plan.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for JNJ — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
Track JNJ insider filings free →This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.